Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

NCT00674440 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
106
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Children's Hospital of Philadelphia

Collaborators